Impaired non-esterified fatty acid suppression to intravenous glucose during late pregnancy persists postpartum in gestational diabetes: A dominant role for decreased insulin secretion rather than insulin resistance

Diabetologia

Volumn 48, Issue 7, 2005, Pages 1373-1379

  McLachlan, K A ^a   Boston, R ^b   Alford, F P ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Beta cell dysfunction; Gestational diabetes; Insulin resistance; Non esterified fatty acids; Pregnancy

Indexed keywords

FATTY ACID; GLUCOSE;

ADULT; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; PANCREAS ISLET DISEASE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PUERPERIUM; THIRD TRIMESTER PREGNANCY; TIME SERIES ANALYSIS;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES, GESTATIONAL; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; INSULIN RESISTANCE; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY TRIMESTER, THIRD;

EID: 23944494299     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1775-6     Document Type: Article

References (25)

1. Oats J, Beischer N (1986) Gestational diabetes. Aust N Z J Obstet Gynaecol 26:2-10
2. Bergman RN, Ader M, Huecking K, Van Citters G (2002) Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 51(Suppl 1):S212-S220
3. Kousta E, Lawrence NJ, Godsland IF et al (2003) Insulin resistance and beta-cell dysfunction in normoglycaemic European women with a history of gestational diabetes. Clin Endocrinol (Oxf) 59:289-297
4. Ward WK, Johnston CL, Beard JC, Benedetti TJ, Halter JB, Porte D Jr (1985) Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus. Diabetes 34:861-869
5. Catalano PM, Nizielski SE, Shao J, Preston L, Qiao L, Friedman JE (2002) Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy. Am J Physiol: Endocrinol Metab 282:E522-E533
6. Homko CJ, Sivan E, Reece EA, Boden G (1999) Fuel metabolism during pregnancy. Semin Reprod Endocrinol 17:119-125
7. Meyer B, Calvert D, Moses R (1996) Free fatty acids and gestational diabetes mellitus. Aust N Z J Obstet Gynaecol 36:255-257
8. Charles MA, Eschwege E, Thibult N et al (1997) The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study. Diabetologia 40:1101-1106
9. Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10
10. Kashyap S, Belfort R, Gastaldelli A et al (2003) A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52:2461-2474
11. Jensen CB, Storgaard H, Holst JJ, Dela F, Madsbad S, Vaag AA (2003) Insulin secretion and cellular glucose metabolism after prolonged low-grade intralipid infusion in young men. J Clin Endocrinol Metab 88:2775-2783
12. Carpentier A, Mittelman S, Bergman R, Giacca A, Lewis G (2000) Prolonged elevation of plasma free fatty acids impairs pancreatic b-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes 49:399-408
13. Paolisso G, Gambardella A, Amato L et al (1995) Opposite effects of short and long term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 38:1295-1299
14. Hoffman L, Nolan C, Wilson JD, Oats JJ, Simmons D (1998) Gestational diabetes mellitus - management guidelines. The Australasian Diabetes in Pregnancy Society. Med J Aust 169:93-97
15. Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN (2003) MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther 5:1003-1015
16. McNair PD, Colman PG, Alford FP, Harrison LC (1995) Reproducibility of the first-phase insulin response to intravenous glucose is not improved by retrograde cannulation and arterialization or the use of a lower glucose dose. Diabetes Care 18:1168-1173
17. Lerner RL, Porte D Jr (1971) Relationship between intravenous glucose loads, insulin responses and glucose disappearance rate. J Clin Endocrinol Metab 33:409-417
18. Albano JD, Ekins RP, Maritz G, Turner RC (1972) A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol (Copenh) 70:487-509
19. Cutfield WS, Bergman RN, Menon RK, Sperling MA (1990) The modified minimal model: application to measurement of insulin sensitivity in children. J Clin Endocrinol Metab 70:1644-1650
20. Henriksen JE, Alford F, Vaag A, Handberg A, Beck-Nielsen H (1999) Intracellular skeletal muscle glucose metabolism is differentially altered by dexamethasone treatment of normoglycemic relatives of type 2 diabetic patients. Metabolism 48:1128-1135
21. Jensen MD, Caruso M, Heiling V, Miles JM (1989) Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes 38:1595-1601
22. Bolinder J, Kager L, Ostman J, Arner P (1983) Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 32:117-123
23. Ader M, Bergman RN (1994) Importance of transcapillary insulin transport to dynamics of insulin action after intravenous glucose. Am J Physiol 266:E17-E25
24. Xiang AH, Peters RK, Trigo E, Kjos SL, Lee WP, Buchanan TA (1999) Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. Diabetes 48:848-854
25. Solomon CG, Willett WC, Carey VJ et al (1997) A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 278:1078-1083